FDA Investigator Bryan L Mcguckin
Bryan L Mcguckin has inspections in 7 countries as of 01 Sep 2023. Bryan L Mcguckin has collaborated with a combined 3587 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
78
Last Inspection Date:
01 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Canada,
Germany,
India,
Taiwan,
Korea (Republic of)
Co-Investigator(s):
Adam J Taylor,
Adetutu M Gidado,
Alecia L Marson,
Alicia K Mckinsey,
Amanda Dinaro,
Amanda S Zorn,
Amina Bashir,
Anders W Evenson,
Anita Narula, PhD,
Anthony C Warchut,
Anthony J Ladner,
Arie C Menachem,
Arsen Karapetyan,
Ashar P Parikh,
Audrey Dela Cruz,
Binh T Nguyen,
Bradley J Maunder,
Brian D Nicholson,
Brian P Emanuel,
Brittany R Laymon,
Bruce H Mccullough,
Bryce H Thompson,
Carl A Huffman, III,
Carrie Ann Plucinski,
Caryn M Everly,
Caryn M Mcnab,
Charles D Brown,
Charles M Edwards,
Chase S Baldwin,
Christina A Miller,
Christina K Theodorou,
Christopher D Leach,
Christopher M Jenner,
Christopher R Czajka,
Claire M Minden,
Clotia Cabbey Mensah,
Colleen M Jones,
Comyar Shoghi,
Crystal Monroy,
Daniel B Arrecis,
Dariusz Galezowski,
David Perkins,
Dawn E Barkans,
Debra I Love,
Debra L Boyd Seale,
Denarvis C Mendenhall,
Dennis Cantellops Paite,
Deyaa Shaheen,
Djamila Harouaka,
Doan T Nguyen, PharmD,
Dogbeda F Mackenzie,
Don H Bark, PhD,
Donald B Mckechnie,
Dr. Carmelo Rosa,
Eileen A Liu,
Elizabeth L Holmes,
Emilie E Kahn,
Eric M Mueller, PharmD,
Eric S Pittman,
Eric S Rittman,
Erin D Mccaffery,
Farhana Khan,
Frederick Razzaghi,
Gam S Zamil,
Gary C Pecic,
Gene D Arcy,
Gerard Pde Leon,
Gregory R Dill,
Guerlain Ulysse,
Gunneet Kaur,
Heika R Tait,
Helen Verdel,
Hugh Grimoldby,
Ivan E Reyes,
James K Ireland,
James W Plucinski,
Janae D Price,
Janet A Rajan,
Jason F Chancey,
Jawaid Hamid,
Jeanne J Chiu,
Jeanne J Thai,
Jeffrey P Raimondi,
Jennifer A D'angelo,
Jennifer C Adams,
Jesse A Vazquez,
Jill J Tillman,
Joan A Loreng,
Jocelyn C Turner,
Joey V Quitania,
Joseph A Morkunas,
Joseph D Cooper,
Joseph M Allen,
Joshua M Adams,
June P Page,
Kaitlyn R Kornberg,
Karen Emasley Joseph,
Karen L Rothschild,
Kathleen S Tormey,
Kenneth O Gee, PhD,
Kerry L Edwards, III,
Kham Phommachanh,
Ko U Min,
Kristen D Jarell,
Langer,
Larry F Hallberg,
Latoya A Griffith,
Lauren A Crivellone,
Laurie A Haxel,
Lequita M Mayhew,
Leslie D Hintz,
Lewis K Antwi,
Lillian S Wu,
Lisa C Lewis,
Lisa Hayka,
Lisa T Michel,
Lorelei S Jarrell,
Maksim A Levenchuk,
Marcellinus D Dordunoo,
Marcia A Worley,
Marcus A Goshen,
Marcus F Yambot,
Margaret Torres Vazquez,
Maria Diaz,
Marie Bbuen Bigornia,
Mary Jeanet Mcgarry,
Mei Chiung J Huang,
Melinda Lee,
Michael L Casner,
Michael R Goga,
Michael R Klapal,
Michele L Glendenning,
Michelle L Dragon,
Min Chu Chen,
Muralidhara B Gavini, PhD,
Nadeem I Chaudhry,
Nancy M Espinal,
Nibin Varghese, MS,
Nicholas F Lyons,
Nicholas Fragedakis,
Nicholas L Hunt,
Nicholas P Diorio,
Nicholas Z Lu,
Nicole A Lloyd,
Nicole S Williams,
Norman K Starks,
Pablo Alcantara,
Patricia A Mcilroy,
Patrick C Klotzbuecher,
Patrick E Gainer,
Paula P Demichael,
Peng Zhou,
Phung Thien Nguyen,
Rajiv R Srivastava,
Reba A Gates,
Richard L Rutherford,
Richmond K Yip,
Roger F Zabinski,
Rose Ljean Mary,
Russell J Glapion,
Russell K Riley,
S Lori Brown, PhD MPH,
Saied A Asbagh,
Samina S Khan,
Samuel A Hamblin,
Samuel T Walker,
Sangeeta M Khurana, PhD,
Santos E Camara,
Sarah A Hassas,
Sarah Nwandiuko,
Seneca D Toms,
Sharna D Pratt,
Sharon K Thoma, PharmD,
Sharon Pratt,
State Agency,
Stephanie A Jameson,
Stephen D Eich,
Sullan,
Sundy Ven,
Susan D Yuscius,
Susan P Bruederle,
Taichun Qin, PhD,
Tamil Arasu, PhD,
That Q Dang,
Thomas J Arista,
Thomas W Nojek,
Thunder N Dunkijacobs,
Todd M Stankewicz,
Todd Q Dang,
Tracey L Harris,
Tracy K Li,
Ucheabuchi C Chudi Nwankwor,
Uttaniti Limchumroon (Tom),
Vioela J Caze,
Virgilio F Pacio, CSO,
Wayne D Mcgrath,
William G Nelson,
William V Millar,
Youkeun Kim,
Yumi J Hiramine,
Yvins Dezan,
Yvonne E Lozano,
Zakaria I Ganiyu,
Zerita White
Bryan L Mcguckin's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more